跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Spectrax - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Spectrax
Approved
STANDARD
Spectrax
Claris Lifescience Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ae22401bedca2580
Company
Claris Lifescience Limited
Type
Standard
Approval Details
Approval Id
ae22401bedca2580
Drug Approval Philippines Name
Spectrax
Product Name
Spectrax
Registration Number
DRP-6588
Brand Name
Spectrax
Generic Name
Cefepime (as Hydrochloride)
Dosage Form
Powder For Injection (IM/IV)
Dosage Strength
1g
Manufacturer
Claris Lifescience Limited
Importer
Claris Lifescience Limited
Distributor
Delex Pharma International Inc.
Issuance Date
26 January 2023
Expiry Date
18 April 2028
Pharmacologic Category
Antibacterial (Cephalosporin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ae22401bedca2580
Type
Standard
Back to Philippines FDA Approvals